Indeed, in PARP-2 deficient mouse models, PARP-2 inhibition was shown to impair the differentiation of erythroid progenitors and shorten the lifespan of erythrocytes, suggesting that exogenous supplementation may not be the most effective means of managing anemia [12, 15, 16]. This evidence concerns the gene PARP2 and anemia.